Trade Mark Journal No.2026/007 13 February 2026

WO0000001898509 (5)

Office of origin: Germany

Date of International Registration:3 December 2025
Date of designation in the UK: 3 December 2025
Image for mark 1898509

International priority date claimed: 12 June 2025 (Germany)
Class 5
Pharmaceuticals for the treatment of cancer.

BioNTech SE

Representative: df-mp Patentanwälte Rechtsanwälte PartG mbB, Theatinerstr. 16, 80333 München, GERMANY